source
- Daraxonrasib uniquely targets active KRAS in pancreatic cancer, says MD Anderson expertDr Shubham Pant, a professor in the Department of Gastrointestinal Medical Oncology at MD Anderson Cancer Center, explained the mechanism of daraxonrasib in a recent commentary. The oral, potent R…
- Experts preview top HR+ and HER2+ breast cancer abstracts ahead of ASCO 2026Preparations are under way for the 2026 ASCO Annual Meeting, and breast cancer updates are generating strong interest among clinicians. Leading oncologists including Dr. Yara Abdou of UNC, Dr. VK…